RPGLFRegent Pacific Group Limited

About Regent Pacific Group Limited (RPGLF)

Regent Pacific Group Limited (RPGLF) is a Drug Manufacturers - Specialty & Generic company headquartered in Central, HK, China whose shares trade over-the-counter on the Pink tier.

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services.

RPGLF key facts

Ticker symbol

RPGLF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Central, HK, China

Country of incorporation

HK

Estimated market cap

$1.68M (as of May 13, 2025)

Shares outstanding

2,399,855,352

Reporting standard

International Reporting: Hong Kong Stock Exchange

Audit status

Not Available

Fiscal year end

12/31

Regent Pacific Group Limited leadership

• Jamie Alexander Gibson — CEO, Executive Director

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with R